BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia.
14 auth. D. Alsop, J. Detre, X. Golay, M. Günther, J. Hendrikse, L. Hernandez-Garcia, Hanzhang Lu, B. MacIntosh, L. Parkes, M. Smits, ... M. V. van Osch, Danny J. J. Wang, E. Wong, G. Zaharchuk
10 2015
10
🐜
🐬 Localizing human visual gamma-band activity in frequency, time and space
N. Hoogenboom, J. Schoffelen, R. Oostenveld, L. Parkes, P. Fries
8 2006
8
🐬
🦁 Normal cerebral perfusion measurements using arterial spin labeling: Reproducibility, stability, and age and gender effects
L. Parkes, W. Rashid, D. Chard, P. Tofts
8 2004
8
🦁
🦁 Improved accuracy of human cerebral blood perfusion measurements using arterial spin labeling: Accounting for capillary water permeability
L. Parkes, P. Tofts
7 2002
7
🦁
🦁 Quantifying the spatial resolution of the gradient echo and spin echo BOLD response at 3 Tesla
7 auth. L. Parkes, J. Schwarzbach, Annemieke A. Bouts, Roel H. R. Deckers, P. Pullens, C. Kerskens, ... D. Norris
7 2005
7
🦁
🦁 Multivoxel fMRI analysis of color tuning in human primary visual cortex.
L. Parkes, J. Marsman, D. C. Oxley, J. Y. Goulermas, S. Wuerger
7 2009
7
🦁
🐢 Blood–Brain Barrier Leakage Is Increased in Parkinson’s Disease
Sarah Al-Bachari, J. Naish, G. Parker, H. Emsley, L. Parkes
7 2020
7
🐢
🦁 Combining EEG and fMRI to investigate the post-movement beta rebound
L. Parkes, M. Bastiaansen, D. Norris
7 2006
7
🦁
🐜 Depressive disorders: focally altered cerebral perfusion measured with arterial spin-labeling MR imaging.
16 auth. S. Lui, L. Parkes, Xiaoqi Huang, K. Zou, R. Chan, Hong Yang, L. Zou, Dongming Li, Hehan Tang, Tijiang Zhang, ... Xiu-Li Li, Yi Wei, Long Chen, Xueli Sun, G. Kemp, Q. Gong
6 2009
6
🐜
🐢 A comparison of dual gradient‐echo and spin‐echo fMRI of the inferior temporal lobe
A. Halai, S. Welbourne, K. Embleton, L. Parkes
6 2014
6
🐢
🦁 Cobalt nanoparticles as a novel magnetic resonance contrast agent--relaxivities at 1.5 and 3 Tesla.
7 auth. L. Parkes, R. Hodgson, L. Lu, L. D. Tung, I. Robinson, D. Fernig, ... Nguyen T. K. Thanh
6 2008
6
🦁